Sphere help find rare and valuable variants, by screening single cells. Our technology boosts assay throughput and sensitivity across multiple applications.
See who you know at Sphere Fluidics Limite leverage your professional network, and get hired. Sphere Fluidics Ltd’s Cyto-Mine device promises to transform the discovery and development of biotherapeutics for treatment of cancer and . Brief A radical new dispensing method was needed by Sphere Fluidics to eject single picoliter volume droplets (picodroplets) on demand during analysis . Encapsulating Biology, Transforming Discovery. SphereFluidics: developing #picodroplets .
University of Cambridge spin-out Sphere Fluidics Limited has won $million in investment for the development of Cyto-mine, a unique single . Cambridge Enterprise portfolio company Sphere Fluidics has been named one of the UK’s top disruptive SMEs by Real Business.